Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going

1mon ago, source: Hosted on MSN

There are several stocks that passed through the screen and Lyra Therapeutics, Inc. (LYRA) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29d ago, source: Business Insider

-- Data from ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Anticipated Q2 2024 -- WATERTOWN, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc ...

Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?

22d ago, source: Nasdaq

Lyra Therapeutics, Inc. LYRA shares ended the last trading session 6.5% higher at $6.53. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Lyra Therapeutics Inc Ordinary Shares

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections

28d ago, source: Yahoo Finance

Warning! GuruFocus has detected 5 Warning Signs with LYRA. On March 21, 2024, Lyra Therapeutics Inc (NASDAQ:LYRA), a clinical-stage biotechnology company, released its 8-K filing, detailing the ...

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

1mon ago, source: Business Insider

WATERTOWN, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company ...

Lyra Therapeutics Stock (NASDAQ:LYRA), Analyst Ratings, Price Targets, Predictions

1mon ago, source: Benzinga.com

Lyra Therapeutics Inc has a consensus price target of $14.6, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from B of A Securities, HC ...

Lyra Therapeutics Inc Ordinary Shares LYRA

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...